These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4839158)

  • 21. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances].
    Storr M; Allescher HD
    Med Monatsschr Pharm; 2003 Aug; 26(8):260-9. PubMed ID: 12953379
    [No Abstract]   [Full Text] [Related]  

  • 22. [Central regulation of the motility of the digestive system with metoclopramide].
    Heynen U
    Z Allgemeinmed; 1969 Mar; 45(7):322-6. PubMed ID: 5778605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial in abdominal surgery of a new molecule, trimebutine, in resumption of postoperative transit].
    Francillon J; Philippe MP
    Lyon Med; 1971 Feb; 225(4):363-5. PubMed ID: 5088602
    [No Abstract]   [Full Text] [Related]  

  • 26. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the spasmolytic efficacy of prifinium bromide in gastrointestinal pathology].
    Garcia Hidalgo E; Fernández Navarro MD; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 May; 37(3):397-406. PubMed ID: 5031449
    [No Abstract]   [Full Text] [Related]  

  • 28. [A comparative ambulatory experiment with Ro 5-3350 (Lexotanil) and oxazepam (author's transl)].
    Ladame FG
    Schweiz Rundsch Med Prax; 1974 Aug; 63(33):1005-8. PubMed ID: 4603298
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse gastrointestinal dysmotility in a patient with rheumatoid arthritis.
    Ljubich P; Parkman HP; Fisher RS; Sorokin JJ; Conaway DC
    Am J Gastroenterol; 1993 Sep; 88(9):1443-5. PubMed ID: 8362846
    [No Abstract]   [Full Text] [Related]  

  • 32. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
    Pasricha PJ
    Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of grandaxin in the treatment of functional gastrointestinal diseases].
    Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG
    Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of the epilepsy using clonazepam (RO 5-4023 - Rivotril)].
    Lorizio A
    Riv Neurobiol; 1972; 18(3-4):233-40. PubMed ID: 4681268
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical activities of a new bezodiazepine: cloxazolam].
    Singer L; Krieger-Finance F; Danion JM
    Ann Med Psychol (Paris); 1980 Jan; 138(1):95-103. PubMed ID: 6104462
    [No Abstract]   [Full Text] [Related]  

  • 37. [The enteric nervous system. Untested field for specific pharmacotherapy].
    Delbro D; Fändriks L; Jodal M; Sjövall H; Lundgren O
    Lakartidningen; 1995 Apr; 92(14):1493-4, 1497-8, 1501-2. PubMed ID: 7707802
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of drugs on intestinal motility.
    Farrar JT
    Clin Gastroenterol; 1982 Sep; 11(3):673-81. PubMed ID: 7140003
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug interactions in gastroenterology].
    Estler CJ
    Fortschr Med; 1980 Dec; 98(47-48):1852-3. PubMed ID: 7216088
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of a new drug for gastrointestinal disorders].
    Jefferson NC
    Rev Esp Enferm Apar Dig; 1968 May; 27(5):796-801. PubMed ID: 5739534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.